[Skip to Content]
[Skip to Content Landing]
Viewpoint
April 10, 2013

The Indispensable Role of Professional Judgment in Genomic Medicine

Author Affiliations

Author Affiliations: Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas (Drs McGuire and McCullough); and Department of Genetics, University of North Carolina School of Medicine, Chapel Hill (Dr Evans).

JAMA. 2013;309(14):1465-1466. doi:10.1001/jama.2013.1438

Whole-genome sequencing and whole-exome sequencing (WGS/WES) have become increasingly affordable and accessible to individuals. There are currently 3 main pathways through which a person can receive WGS/WES: as a research participant in a genomic study; through a direct-to-consumer personal genome company; or as part of clinical care. In the research context, the extent to which findings from WGS/WES are communicated to study participants and used to inform their clinical care is a topic of much debate, but guidelines suggest that investigators may have an obligation to offer at least some results to study participants.1

×